Compare CCO & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCO | PAHC |
|---|---|---|
| Founded | 1995 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2005 | 2014 |
| Metric | CCO | PAHC |
|---|---|---|
| Price | $2.40 | $34.38 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 4 |
| Target Price | $2.12 | ★ $41.25 |
| AVG Volume (30 Days) | ★ 6.5M | 277.6K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | 110.81 | ★ 1883.33 |
| EPS | N/A | ★ 1.90 |
| Revenue | ★ $1,604,140,000.00 | $833,350,000.00 |
| Revenue This Year | $5.35 | $17.03 |
| Revenue Next Year | $4.26 | $3.82 |
| P/E Ratio | ★ N/A | $17.84 |
| Revenue Growth | ★ 6.57 | 4.12 |
| 52 Week Low | $1.00 | $25.58 |
| 52 Week High | $2.43 | $60.08 |
| Indicator | CCO | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 50.27 | 56.03 |
| Support Level | $2.37 | $30.46 |
| Resistance Level | $2.41 | $34.57 |
| Average True Range (ATR) | 0.02 | 1.27 |
| MACD | -0.00 | 0.48 |
| Stochastic Oscillator | 25.00 | 87.10 |
Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.